A two-drug combination destroys precancerous colon polyps with no effect on normal tissue, opening a new potential avenue for chemoprevention of colon cancer, a team of scientists at The University of Texas M. D. Anderson Cancer Center reports in the advance online edition of the journal Nature. The regimen, tested so far in mouse models and on human colon cancer tissue in the lab, appears to address a problem with chemopreventive drugs - they must be taken continuously long term to be effective, exposing patients to possible side effects, said senior author Xiangwei Wu, Ph.D…

View original here: 
Paired Drugs Kill Precancerous Colon Polyps, Spare Normal Tissue

You may also like:

• Diabetes Raises Risk Of Death In Cancer Surgery Patients
• Childhood Cancer Patients Enrolled In Clinical Trials Need Clearer Communication About Their Role In Research
• Fibrates Prevent Coronary Events And Could Have Role In Heart Protection
• New Genetic Risk Factors For Aneurysms Identified By Yale-Led Team
• Key Protein Links Insulin Action, Insulin Resistance In Diabetes
• Location Of Body Fat Affects Risk Of Blood Clots
• Milk is safe after treatment for milk allergy
• Survey Reveals Cereal Tops The List Of Preferred Ways To Serve A Quick And Nutritious Breakfast
• GE Awarded $538,000 Grant From National Institutes Of Health For Human Microbiome Studies
• Can-Fite BioPharma Announces The Initiation Of Phase 3 In Dry Eye Syndrome